v3.26.1
Condensed Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Total Shareholders' Equity
Preferred Stock
Common Stock
Additional Paid-In Capital
Treasury Stock at Cost
Accumulated Other Comprehensive Income
Retained Earnings
Non-Controlling Interests
Balance beginning of period at Dec. 31, 2024 $ 9,982 $ 9,764 $ 533 $ 1 $ 6,046 $ (1,007) $ (3,522) $ 7,713 $ 218
Balance end of period at Mar. 31, 2025 10,525 10,301 533 1 6,042 (1,179) (2,719) 7,623 224
Balance beginning of period at Dec. 31, 2024 9,982 9,764 533 1 6,046 (1,007) (3,522) 7,713 218
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 167 155           155 12
Other comprehensive income (loss) 899 899         899    
Change in equity of noncontrolling interests 18               18
Dividends on preferred stock (22) (22)           (22)  
Dividends on common stock (117) (117)           (117)  
Purchase of treasury stock (360) (360)       (360)      
Share based compensation 35 35     1 30   4  
Balance end of period at Jun. 30, 2025 10,602 10,354 533 1 6,047 (1,337) (2,623) 7,733 248
Balance beginning of period at Dec. 31, 2024 9,982 9,764 533 1 6,046 (1,007) (3,522) 7,713 218
Balance end of period at Dec. 31, 2025 10,342 9,953 533 1 6,063 (1,645) (2,470) 7,471 389
Balance beginning of period at Mar. 31, 2025 10,525 10,301 533 1 6,042 (1,179) (2,719) 7,623 224
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 185 179           179 6
Other comprehensive income (loss) 96 96         96    
Change in equity of noncontrolling interests 18               18
Dividends on preferred stock (11) (11)           (11)  
Dividends on common stock (58) (58)           (58)  
Purchase of treasury stock (158) (158)       (158)      
Share based compensation 5 5     5        
Balance end of period at Jun. 30, 2025 10,602 10,354 533 1 6,047 (1,337) (2,623) 7,733 248
Balance beginning of period at Dec. 31, 2025 10,342 9,953 533 1 6,063 (1,645) (2,470) 7,471 389
Balance end of period at Mar. 31, 2026 9,900 9,496 533 1 6,393 (1,671) (2,728) 6,968 404
Balance beginning of period at Dec. 31, 2025 10,342 9,953 533 1 6,063 (1,645) (2,470) 7,471 389
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 240 231           231 9
Other comprehensive income (loss) (155) (155)         (155)    
Change in equity of noncontrolling interests 114               114
Dividends on preferred stock (22) (22)           (22)  
Dividends on common stock (128) (128)           (128)  
Purchase of treasury stock (454) (454)       (454)      
Issuance of treasury stock 500 500     322 178      
Share based compensation 37 37     16 24   (3)  
Balance end of period at Jun. 30, 2026 10,474 9,962 533 1 6,401 (1,897) (2,625) 7,549 512
Balance beginning of period at Mar. 31, 2026 9,900 9,496 533 1 6,393 (1,671) (2,728) 6,968 404
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 660 655           655 5
Other comprehensive income (loss) 103 103         103    
Change in equity of noncontrolling interests 103               103
Dividends on preferred stock (11) (11)           (11)  
Dividends on common stock (63) (63)           (63)  
Purchase of treasury stock (227) (227)       (227)      
Share based compensation 9 9     8 1   0  
Balance end of period at Jun. 30, 2026 $ 10,474 $ 9,962 $ 533 $ 1 $ 6,401 $ (1,897) $ (2,625) $ 7,549 $ 512